← All news
Markets
Argenx Soars on Latest Trial Success for Autoimmune Drug Vyvgart
Argenx SE’s shares jumped after the European biotech reported the latest large, successful trial for its blockbuster drug Vyvgart.
Covered by 1 outlet
All coverage · 1 article